The association of anti-annexin1 antibodies with the occurrence of skin lesions in systemic lupus erythematosus

Lupus

Volumn 23, Issue 2, 2014, Pages 183-187

  Meng, Z ^a   Shi, Z R ^a   Tan, G Z ^a   Yin, J ^b   Wu, J ^c   Mi, X B ^d   Wang, L ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b Affiliated Hospital of Shandong   (China)

^c GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^d SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

annexin1; anti annexin1 antibodies; cutaneous lesion; Systemic lupus erythematosus

Indexed keywords

ANTIBODY; HEMOGLOBIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LIPOCORTIN 1; LIPOCORTIN 1 ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMIS; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; IMMUNOLOGY TEST KIT; LEUKOCYTE; MALE; MICROPLATE READER; MICROSCOPE; PRIORITY JOURNAL; SKIN BIOPSY; SKIN DEFECT; SYSTEMIC LUPUS ERYTHEMATOSUS; WESTERN BLOTTING;

ANNEXIN1; ANTI-ANNEXIN1 ANTIBODIES; CUTANEOUS LESION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANNEXIN A1; AUTOANTIBODIES; CASE-CONTROL STUDIES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOHISTOCHEMISTRY; LUPUS ERYTHEMATOSUS, SYSTEMIC; SKIN;

EID: 84892589870     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203313513820     Document Type: Article

References (13)

1. Flower RJ, Rothwell NJ. Lipocortin-1: Cellular mechanisms and clinical relevance. Trends Pharmacol Sci. 1994 ; 15: 71-76
2. D'Acquisto F, Perretti M, Flower RJ. Annexin-A1: A pivotal regulator of the innate and adaptive immune systems. Br J Pharmacol. 2008 ; 155: 152-169
3. Lim LH, Pervaiz S. Annexin 1: The new face of an old molecule. Faseb J. 2007 ; 21: 968-975
4. Huitinga I, Bauer J, Strijbos PJ, Rothwell NJ, Dijkstra CD, Tilders FJ. Effect of annexin-1 on experimental autoimmune encephalomyelitis (EAE) in the rat. Clin Exp Immunol. 1998 ; 111: 198-204
5. Probst-Cousin S, Kowolik D, Kuchelmeister K, Kayser C, Neundorfer B, Heuss D. Expression of annexin-1 in multiple sclerosis plaques. Neuropathol Appl Neurobiol. 2002 ; 28: 292-300
6. Goulding NJ, Podgorski MR, Hall ND, et al. Autoantibodies to recombinant lipocortin-1 in rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis. 1989 ; 48: 843-850
7. Kretz CC, Norpo M, Abeler-Dorner L, et al. Anti-annexin 1 antibodies: A new diagnostic marker in the serum of patients with discoid lupus erythematosus. Exp Dermatol. 2010 ; 19: 919-921
8. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 ; 25: 1271-1277
9. Duffy KN, Duffy CM, Gladman DD. Infection and disease activity in systemic lupus erythematosus: A review of hospitalized patients. J Rheumatol. 1991 ; 18: 1180-1184
10. Arur S, Uche UE, Rezaul K, et al. Annexin I is an endogenous ligand that mediates apoptotic cell engulfment. Dev Cell. 2003 ; 4: 587-598
11. Pruzanski W, Goulding NJ, Flower RJ, et al. Circulating group II phospholipase A2 activity and antilipocortin antibodies in systemic lupus erythematosus. Correlative study with disease activity. J Rheumatol. 1994 ; 21: 252-257
12. Fava RA, Nanney LB, Wilson D, King LE Jr. Annexin-1 localization in human skin: Possible association with cytoskeletal elements in keratinocytes of the stratum spinosum. J Invest Dermatol. 1993 ; 101: 732-737
13. Elderfield AJ, Bolton C, Flower RJ. Lipocortin 1 (annexin 1) immunoreactivity in the cervical spinal cord of Lewis rats with acute experimental allergic encephalomyelitis. J Neurol Sci. 1993 ; 119: 146-153